RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases.
The Company is focused on solutions for some of the most challenging human pathogens: HIV, HCV, and other serious infections. RetroVirox was founded with an initial investment by scientists and entrepreneurs to translate into cures research previously funded by the National Institutes of Health (NIH).
RetroVirox is headquartered in San Diego, California
